Case 11 Pharmacology Flashcards
(55 cards)
Plasma glucose normal range
- 0-6.0mmol/L (72-108 mg/dL) fasting
7. 8mmol/L (140mg/dL) 2 hours after eating
Endocrine secretions of the pancreas
Glucagon
Somatostatin
Pancreatic polypeptide
Exocrine secretions
Digestive juices and bicarbonate in duodenum
Insulin secretion MOA
Regulated by glucose transport into B cells by GLUT-2.
ATP inhibiting K+ATP efflux channels increased by glucokinas.
Ca2+ influx then insulin secretion via IP3 pathways
Insulin regulates metabolism of…
Carbs, lipids, proteins
Which type of transmembrane linked receptor is insulin
Tyrosine-kinase
Which glucose transporter is a low affinity glucose transporter
GLUT-2
What triggers secretion of insulin in the blood stream?
Glucose sensing in the pancreatic beta cell
Insulin blocks which processes
Glycogenolysis Proteolysis Ketogenesis Gluconeogenesis Lipolysis
Insulin causes which processes
K+ uptake Protein synthesis Glycogen synthesis Glucose uptake Glycolysis
HbA1c- glycated or glycosylated ?
Glycated.
Higher the number- higher the glycaemic control required
AGE full form?
Advanced glycation end-products
Glycation is a non-enzymatic reaction that proceeds under hyperglycaemia and aging
Normal HbA1c?
<42 mmol/mol (or below 6% of Hb)
Plasma glucose hypo or hyper
<4.0 mmol/L- HYPO
>6.9 mmol/L HYPER
Diabetes complications?
Macrovascular disease, gangrene, microangiopathy, peripheral neuropathy, chronic renal failure, diabetic nephropathy, diabetic cardiomyopathy
Insulin sensitive effect by which receptor?
GLP-1
They are insulin sensitisers, - regulated by DPP-IV
Metformin class and administration
Biguanide- orally administered- FIRST-LINE
Metformin MOA (only works if there is SOME endogenous insulin production)
Insulin sensitizer
Causes reduction of ATP in liver cells, increased AMP- inhibits, glycerol 3-PDH
NADH goes up and gluconeogenesis goes down
Lactate increases
Appetite depressant
Sulfonylureas- eg Gliclazide MOA
Binds to the K+ ATP channel receptor .
BLOCKS K+ efflux
B cell depolarises causing Ca2+ influx
IP3 cascade- enhanced insulin granule
GLIPTINS- saxagliptin- MOA
Inhibitor of DPP-IV. Therefore GLP-1 has an EXTENDED effect on insulin secretion
Super-sensitises insulin secretion
GLP-1 agonists Incretin mimetics - Exenatide-MOA and route
S.c injection
Analogues of the incretins- you have to inject the drug
Activates the GLP-1 receptor
Enhances insulin secretion from B cells, suppresses glucagon secretions and slows gastric emptyping
SGL2-inhibitors- Gliflozins- eg dapagliflozin- MOA
Inhibition of the Na+/gllucose symporter in the nephron
Enhanced secretion of glucose in the urine to reduce plasma glucose concentration
Exogenous insulin?
Exogenously prepared insulin may be considered
At which HbA1c value should you add a second drug?
7.5%